EcoDrugPlus

Checkpoint Kinase 1

Ensembl ID : ENSPVAG00000004535
Gene Symbol: CHEK1
1 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSPVAG00000004522
Gene Symbol: CHEK2
1 Cross references
205 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSPVAG00000014200
Gene Symbol: CCKAR
1 Cross references
200 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSPVAG00000002407
Gene Symbol: CCKBR
1 Cross references
264 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSPVAG00000016580
Gene Symbol: CHRM3
1 Cross references
255 Possible Orthologues:

Cholinergic Receptor Muscarinic 5

Ensembl ID : ENSPVAG00000003820
Gene Symbol: CHRM5
1 Cross references
263 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 3 Subunit

Ensembl ID : ENSPVAG00000009191
Gene Symbol: CHRNA3
1 Cross references
207 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 4 Subunit

Ensembl ID : ENSPVAG00000014109
Gene Symbol: CHRNA4
1 Cross references
204 Possible Orthologues:

Cholinergic Receptor Nicotinic Beta 4 Subunit

Ensembl ID : ENSPVAG00000009193
Gene Symbol: CHRNB4
1 Cross references
198 Possible Orthologues:

Chymase 1

Ensembl ID : ENSPVAG00000007049
Gene Symbol: CMA1
1 Cross references
293 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSPVAG00000009728
Gene Symbol: F2R
1 Cross references
327 Possible Orthologues:

Coagulation Factor Ii, Thrombin

Ensembl ID : ENSPVAG00000015792
Gene Symbol: F2
1 Cross references
85 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).